Phase
Condition
Helicobacter Pylori
Treatment
Vonoprazan
Amoxicillin
vonoprazan
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age from 18 to 65 years;
H.pylori infection diagnosed by 13C-urea breath test;
A period of more than two months since the last eradication therapy for H. pylori;
Patients who had previously failed 2 or more eradication regimens.
Exclusion
Exclusion Criteria:
Allergy to any of the medications;
Zollinger-Ellison syndrome, GC, Upper gastrointestinal bleeding, or Active pepticulcer;
Coexistence of significant concomitant illnesses, including heart disease, renalfailure, hepatic disease, previous abdominal surgery, lactation, or pregnancy;
Patients who had used probiotics, vonoprazan, and antibiotics in the past 12 weeks;
Unwillingness to participate in this study.
Study Design
Study Description
Connect with a study center
Zhongshan Hospital (Xiamen), Fudan University
Xiamen, Fujian 361015
ChinaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.